- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02528669
Patient Ambulation in Post-Op Recovery
Measuring Patient Ambulation in Post-Operative Recovery
Study Overview
Detailed Description
Early ambulation in post-operative patients has shown benefits including shorter length of stay and/or fewer complications. Accelerometers have been found as useful instruments in encouraging ambulation in patients. Accelerometers are non-invasive devices that can evaluate changes in movement, gait, and ambulatory activity. Although these devices can be beneficial, little research exists on the best way to engage patients in ambulation, how to develop a standard ambulation protocol, and the best algorithms to measure ambulation post-operation. This study seeks to develop a standardized activity tracker and program that will encourage patient ambulation and allow patients and healthcare providers to view the progress of daily walking goals.
A total of 3,000 patients will be asked if they would like to participate in this study. A healthcare provider will explain to the patient the benefits of getting out of bed, sitting, and walking after an invasive procedure. Patients who decide to participate will be given an accelerometer during their pre-operation visit or after their surgery while still in the hospital. Patients will be asked to wear the accelerometer continuously during waking hours. The accelerometer will provide patients with daily walking goals, reminders of when it is time to walk, track step count, record time of walk, and duration of walk. Patients will be asked to wear the accelerometer until their post-op visit (about 30 days).
The following data points will be analyzed:
- Relationship between ambulation and patient outcomes
- Relationship between ambulation and other health factors
- Effectiveness of prototype platform to motivate and monitor patient activity
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Utah
-
Murray, Utah, United States, 84107
- Intermountain Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients of physician study investigators
Exclusion Criteria:
- Patients whose physicians find they are unfit to participate in a walking program
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RX Navigait
Individuals in this group will be given an activity tracking device that receives and displays walking reminders and daily walking goals.
In addition, they will be given additional education about the benefits of walking.
The device will track daily steps taken, minutes of walking, and frequency of walking bouts throughout the day.
|
The RX Navigait is an accelerometer that tracks the number to steps taken, duration of walking, and time of walking.
In addition, this device sends messages to patients regarding daily walking goals and walking reminders.
|
No Intervention: Control Group
Participants in this group will be given an activity tracking device that receives and displays walking reminders and daily walking goals but will not receive additional education regarding the benefits of walking.
The device will track daily steps taken, minutes of walking, and frequency of walking bouts throughout the day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient Ambulation (number of steps, frequency, time)
Time Frame: Up to 3 months
|
Up to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Accuracy of accelerometer algorithms measuring post operation walking
Time Frame: Up to three years
|
Up to three years
|
Number of patients completing ambulation program
Time Frame: Up to three years
|
Up to three years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mark Ott, MD, Intermountain Health Care, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1024875
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPhysical Activity | Activity TrackersUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on RX Navigait
-
Abbott Medical DevicesCompletedCarotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy (CANOPY)Stroke | Carotid Artery Disease | Amaurosis Fugax | Transient Ischemic Attack (TIA)United States
-
Abbott Medical DevicesCompleted
-
Atrium Medical CorporationCompletedHypertension, Renovascular | Renal Artery StenosisUnited States
-
Abbott Medical DevicesCompleted
-
Unity Health TorontoRecruitingMCI | Amnestic Mild Cognitive DisorderCanada
-
Processa PharmaceuticalsCompletedSolid Tumor | Metastatic Bladder CancerUnited States
-
Kaiser PermanenteUnity HealthActive, not recruitingPhysical Activity | Mental Health Wellness 1United States
-
C.T. Development America, Inc.Completed